120.23USD-13.52%Mkt Cap: 7.06B USDP/E: —Last update: 2026-05-22
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It off…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.7
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap7.06B USD
Enterprise Value7.99B USD
Revenue (TTM)551.35M USD
Gross Profit282.76M USD
Net Income (TTM)-187.69M USD
Revenue/Share9.583 USD
Last Price120.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS3773221029
Valuation
P/E (Trailing)—
P/E (Forward)290.15
PEG—
EV/EBITDA-180.60
EV/Revenue14.49
P/S14.81
P/B12.09
EPS (TTM)-3.30
EPS (Forward)0.48
52W Range
73.1663% of range148.11
52W High148.11 USD
52W Low73.16 USD
Profitability
Gross Margin55.72%
Oper. Margin-13.19%
EBITDA Margin-8.02%
Profit Margin-36.99%
ROE-28.60%
ROA-21.01%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.79M USD
CapEx (TTM)24.27M USD
FCF Margin1.10%
FCF Yield0.09%
Net Debt-170.82M USD
Net Debt/EBITDA3.86
Balance Sheet
Debt/Equity0.16
Current Ratio5.43
Quick Ratio4.43
Book Value/Sh11.50 USD
Cash/Share4.713 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)151.08 USD
Target Range136.00 USD – 170.00 USD
# Analysts12
Ownership
Shares Out.58.73M
Float57.72M
Insiders3.58%
Institutions101.87%
Short Interest
Short Ratio4.0d
Short % Float6.00%
Short % Out.4.95%
Shares Short2.91M
Short (prev mo.)3.10M
Technical
SMA 50121.06 (-0.7%)
SMA 200105.13 (+14.4%)
Beta0.95
S&P 52W Chg28.31%
Avg Vol (30d)849.93K
Avg Vol (10d)774.50K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—